DNA levels in blood tracked during cancer operations

NCT ID NCT03284684

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how DNA from tumors changes in the blood before, during, and after surgery for breast, prostate, or colon cancer. Thirty adults having curative surgery provided blood samples to measure these DNA levels. The goal was to understand the natural pattern of DNA changes, which can help design future studies on how different surgical techniques or drugs might affect cancer spread.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colon adenocarcinoma colon carcinoma colonic neoplasm invasive breast carcinoma prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER COLON CANCER PROSTATE CANCER

Contacts and locations

Locations

CHU Montpellier

Montpellier, 34295, France
CHU Nimes

Nîmes, 30029, France
Institut de Cancérologie Montpellier

Montpellier, 34298, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.